Virtual Ward for Early Discharge in Patients Receiving Inpatient Care (NCT06936891) | Clinical Trial Compass
RecruitingNot Applicable
Virtual Ward for Early Discharge in Patients Receiving Inpatient Care
Netherlands306 participantsStarted 2025-04-16
Plain-language summary
This study evaluates the feasibility of providing hospital-level care at home for eligible patients through a Virtual Ward. Patients are discharged early from the hospital and monitored remotely using digital vital sign monitoring and anamnesis questionnaires. The primary aim is to determine if at least 30% of eligible patients can be safely and successfully transferred to the Virtual Ward under current Dutch healthcare conditions.
Who can participate
Age range
18 Years
Sex
ALL
See this in plain English?
AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.
Inclusion Criteria:
* Adult patients (≥18 years old).
* Currently hospitalized and eligible for early discharge according to clinical judgment.
* Ability to provide written informed consent.
* Access to a smartphone or tablet with internet connection.
* Patient is capable of using the Digizorg app or has support from a caregiver who can assist.
* Suitable home situation for Virtual Ward care (e.g., safe environment, necessary utilities available).
* Enrollment in one of the predefined Virtual Ward care pathways
Exclusion Criteria:
* Patients requiring continuous hospital-based monitoring or interventions that cannot be safely delivered at home.
* Patients who are hemodynamically unstable or require oxygen therapy \>5 liters/minute at the time of discharge.
* Patients unable or unwilling to comply with home monitoring procedures.
* Patients with significant cognitive impairment without adequate caregiver support.
* Patients with a life expectancy less than 30 days, as assessed by the treating physician.
* Patients participating in another interventional clinical trial that could interfere with the Virtual Ward protocol.
* Any other condition that, in the opinion of the treating physician, would make participation unsafe or infeasible.
Questions worth asking your doctor
Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.
1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?
Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.
Questions for the trial coordinator
The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.
1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?
A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.
What they're measuring
1
Number of Participants Successfully Transferred to the Virtual Ward After Providing Informed Consent
Timeframe: From enrollment to transfer to Virtual Ward (during hospitalization, up to 7 days)